A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis

American Journal of Gastroenterology

Volumn 94, Issue 10, 1999, Pages 3000-3004

  Baruch, Yaacov ^a,c   Assy, Nimer ^a   Weisbruch, Felix ^a   Reisner, Shimon A ^a,c   Rinkevich, Diana ^a   Enat, Rafael ^a,c   Blendis, Lawrence M ^b   Bomzon, Arieh ^c,d  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; BILE ACID BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CORONARY HEMODYNAMICS; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HEART OUTPUT; HEART RATE; HUMAN; LIVER CIRRHOSIS; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 0032820121     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01450.x     Document Type: Article

References (28)

1. Rosser B.G., Gores G.J. Liver cell necrosis Cellular mechanisms and clinical implications . Gastroenterology. 108:1995;252-275.
2. Paumgartner G. Serum bile acids. Physiological determinants and results in liver disease. J Hepatol. 2:1986;291-298.
3. Poupon R.E., Lindor K.D., Cauch-Dudek K., et al. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 113:1997;884-890.
4. Ostrow J.D. Metabolism of bile salts in cholestasis in humans. Tavoloni N., Berk P.D. Hepatic transport and bile secretion Physiology and pathophysiology . 1993;673-712 Raven Press, Ltd, New York.
5. Tominaga T., Suzuki H., Ogata Y., et al. Bile acids are able to reduce blood pressure by attenuating vascular reactivity in spontaneously hypertensive rats. Life Sci. 42:1988;1861-1868.
6. Joubert P. An in vivo investigation of the negative chronotropic effect of cholic acid in the rat. Clin Exp Pharmacol Physiol. 5:1978;1-8.
7. Joubert P. Cholic acid and the heart In vitro studies of the effect on heart rate and myocardial contractility in the rat . Clin Exp Pharmacol Physiol. 5:1978;9-16.
8. Bomzon A., Ljubuncic P. Cardiovascular toxicity of bile acids. Arch Toxicol Kinet Xenobiot Metab. 3:1995;1-12.
9. Alon U., Berant M., Mordechovitz D., et al. Effect of isolated cholaemia on systemic haemodynamics and kidney function in conscious dogs. Clin Sci. 63:1982;59-64.
10. Alon U., Berant M., Mordechovitz D., et al. The effect of intrarenal infusion of bile on kidney function in the dog. Clin Sci. 62:1982;431-433.
11. Levy M., Finestone H. Renal response to four hours of biliary obstruction in the dog. Am J Physiol. 244:1983;F516-F525.
12. Better O.S., Guckian V., Giebisch G., et al. The effect of sodium taurocholate on proximal tubular reabsorption in the rat kidney. Clin Sci. 72:1987;139-141.
13. Dillingham M.A., Better O.S., Anderson R.J. Sodium taurocholate increases hydraulic conductivity in rabbit collecting tubule. Kidney Int. 33:1988;782-786.
14. Stiehl A., Rudolph G., Raedsch R., et al. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology. 12:1990;492-497.
15. Heathcote E.J., Cauch-Dudek K., Walker V., et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 19:1994;1149-1156.
16. Fernandez-Seara J., Prieto J., Quiroga J., et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure. Gastroenterology. 97:1989;1304-1312.
17. Pak J.-M., Lee S.S. Vasoactive effects of bile salts in cirrhotic rats In vivo and in vitro studies . Hepatology. 18:1993;1175-1181.
18. Pak J.-M., Adeagbo A.S.O., Triggle C.R., et al. Mechanism of bile salt vasoactivity Dependence on calcium channels in vascular smooth muscle . Br J Pharmacol. 112:1994;1209-1215.
19. Bomzon A., Ljubuncic P. Bile acids as endogenous vasodilators? Biochem Pharmacol. 49:1995;581-589.
20. Said O., Ljubuncic P., Ehrlich Y., et al. Bile acids and vasorelaxation. Can J Physiol Pharmacol. 72:1994;50. (abstract).
21. Kvietys P.R., McLendon J.M., Granger D.N. Postprandial intestinal hyperemia Role of bile salts in the ileum . Am J Physiol. 241:1981;G469-G477.
22. Heuman D.M. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res. 30:1989;719-730.
23. Roda A., Minutello A., Angellotti M.A., et al. Bile acid structure-activity relationship Evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC . J Lipid Res. 31:1990;1433-1444.
24. Moller S., Henriksen J.H. Neurohumoral fluid regulation in chronic liver disease. Scand J Clin Lab Invest. 58:1998;361-372.
25. La Villa G., Arroyo V. Pathophysiology and treatment of ascites in cirrhosis. Trop Gastroenterol. 11:1990;56-75.
26. Jacob G., Nassar N., Hayam G., et al. Cardiac function and responsiveness to β-adrenoceptor agonists in rats with obstructive jaundice. Am J Physiol. 265:1993;G314-G320.
27. Ma Z.H., Lee S.S. Cirrhotic cardiomyopathy Getting to the heart of the matter . Hepatology. 24:1996;451-459.
28. Wong F., Bomzon A., Liu P., et al. Effects of ursodeoxycholic acid on systemic, renal and forearm hemodynamics and sodium homeostasis in cirrhotic patients with refractory ascites. Clin Sci. 96:1999;467-474.